Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
EU Enlargement Commissioner Coase: The pace of reform implementation has slowed significantly.
2025-11-04
EU Enlargement Commissioner Coase: The pace of reform implementation has slowed significantly.
Back
Other News
2025-11-04
CStone Pharmaceuticals-B (02616.HK): Today announced that its Investigational New Drug (IND) application for the combination therapy of CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) for advanced solid tumors has been approved by the National Medical
CStone Pharmaceuticals-B (02616.HK): Today announced that its Investigational New Drug (IND) application for the combination therapy of CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) for advanced solid tumors has been approved by the National Medical Products Administration (NMPA) of China.
2025-11-04
Ferrari reported third-quarter revenue of €1.77 billion, exceeding market expectations of €1.71 billion; and third-quarter EBIT of €503 million, exceeding market expectations of €471 million.
Ferrari reported third-quarter revenue of €1.77 billion, exceeding market expectations of €1.71 billion; and third-quarter EBIT of €503 million, exceeding market expectations of €471 million.
Chat with us
, powered by
LiveChat